Baptist Health has received 3,900 doses of the Pfizer COVID-19 vaccine. According to Baptist Health spokesperson Kadie Agnew, a vaccine administration plan is in the works. She says it’s hoped that more information will be released by the end of the week. As Alabama News Network has reported, the Pfizer vaccine is being shipped directly to 15 Alabama hospitals which have the…
A truck loaded with the Pfizer-BioNTech COVID-19 vaccine leaves the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Mich., Sunday, Dec. 13, 2020. (AP Photo/Morry Gash, Pool) The first trucks carrying a COVID-19 vaccine for widespread use in the United States have pulled out of a manufacturing plant in Kalamazoo, Michigan. The shipments this morning set in motion the biggest…
The U.S. has given the final go-ahead to the nation’s first COVID-19 vaccine, launching emergency vaccinations in a bid to end the pandemic. Shots will begin in a few days after Friday’s decision by the Food and Drug Administration. The FDA called the vaccine from Pfizer and its German partner BioNTech safe and strongly protective. But initial doses are scarce…
WASHINGTON (AP) – Pfizer’s COVID-19 vaccine faces one final hurdle before an expected decision to greenlight the shot for use in millions of Americans. Food and Drug Administration advisers meet Thursday to scrutinize the company’s data for any red flags or oversights. The public review comes as U.K. regulators investigate two apparent cases of allergic reaction to the vaccine. Safety…
Scientists at the University of Alabama at Birmingham say they aim to begin enrolling patients soon for a clinical trial of a COVID-19 vaccine. Dr. Paul Goepfert, director of UAB’s Alabama Vaccine Research Clinic, says the clinic hopes to get approval this week to start enrolling patients in a study to test the effectiveness of a COVID vaccine being manufactured…
Pfizer is set to ask U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month. Friday’s step comes days after Pfizer and its German partner BioNTech announced its vaccine appears 95% protective in a large but not yet finished study. Over the next few weeks, the Food…
Dr. Anthony Fauci testified says 250,000 people have registered on a National Institutes of Heath website to take part in experimental vaccine trials. The study of the first vaccine involving 30,000 people began this week. The U.S. government plans to launch studies of additional vaccines every month through the fall. Trials are pivotal for establishing the safety and effectiveness of…
